Evidence map›Paper›PMID 38872012›Full record

ArticleNature chemical biology2024

The realization of CRISPR gene therapy.

Yitong Ma, Lei S Qi

Abstract read
In one paragraph

Article in Nature chemical biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Engineering Immune Cell to Counteract Aging and Aging-Associated Diseases.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  2. Review
  3. Review
  4. 20 years of Nature Chemical Biology.Nature chemical biology · 2025
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yitong MaDepartment of Bioengineering, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0003-4446-7326
Lei S QiDepartment of Bioengineering, Stanford University, Stanford, CA, USA. slqi@stanford.edu.ORCID http://orcid.org/0000-0002-3965-3223

Funding

Manipulating and Interrogating Spatial TranscriptomicsDP1NS137219 · NINDS · STANFORD UNIVERSITY · PI Lei Stanley Qi · 2023 to 2026
$4.3M
Development of multi-color 3D super-localization LiveFISH and LiveFISH PAINT to investigate the chromatin dynamics at any genomic scaleR21HG013133 · NHGRI · STANFORD UNIVERSITY · PI QI, LEI STANLEY · 2023 to 2023
$420k
Cancer Research Institute (CRI) CRI5247NHGRI NIH HHS R21 HG013133NINDS NIH HHS DP1 NS137219U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (NHGRI) R21HG013133U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) DP1NS137219
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CRISPR-Cas SystemsGene EditingGenetic TherapyAnimalsClustered Regularly Interspaced Short Palindromic RepeatsHumans

Identifiers

PMID38872012
PMCPMC12096820

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.